US4460694A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bovine glycoproteins and use in diagnosing infectious mononucleosis
Assignee: MIAMI A NOT FOR PROFIT CORP, University of
•
Filing: 1982-03-09
•
Granted: 1984-07-17
•
Expires: 2002-03-09
Abstract
Abstract A novel purification scheme is described for obtaining two novel and useful forms of bovine glycoprotein (BGP) from bovine erythrocytes, each of which acts as an antigen in testing for the presence of the heterophile antibodies of human infectious mononucleosis. The first, or partially purified, BGP is obtained from crude BGP and contains about 10% by weight of a complex glycoplipid. It forms a single band upon gel electrophoresis at pH 7.0 under specified conditions. The second, or homogeneous, BGP is obtained by removing essentially all of the complex glycolipid. It forms substantially a single band upon gel electrophoresis at pH 7.0 under specified conditions. Both forms may be used to detect or quantify hemagglutination inhibition of a test sample (and hence to determine the presence or extent to mononucleosis infection) in a glass slide test wherein the partially purified or homogeneous BGP is carried on latex or synthetic resin beads. The homogeneous BGP is also useful in an immunoassay, preferably a radioimmunoassay, for heterophile antibodies characteristic of infectious mononucleosis.
Inventors
- 👤 Mary A. Fletcher
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:21
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56983; A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/18; C; C07; C07K; C07K14/00; C07K14/435; C07K14/705; G01N33/68; G01N33/6854; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/804; Y10S436/811; Y10S436/812; Y10S530/00; Y10S530/81; Y10S530/812; Y10S530/815
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
96 words
A bovine glycoprotein, the amino acid composition of which is in the order of about 7.2 mole % aspartic acid, about 8 mole % threonine, about 7.2 mole % serine, about 16.5 mole glutamic acid, about 12.9 mole % proline, about 8.9 mole % glycine, about 5.6 mole % alanine, about 5.4 mole % valine, about 1.2 mole % methionine, about 6.4 mole % isoleucine, about 9.2 mole % leucine, about 0.9 mole % tyrosine, about 2.8 mole % phenylalanine about 1.3 mole % histidine, about 1.8 mole % lysine and about 4.8 mole % arginine.
Claim 2
Dependent Claim
96 words
A bovine glycoprotein, the amino acid composition of which is in the order of about 7.2 mole % aspartic acid, about 8 mole % threonine, about 7.2 mole % serine, about 16.5 mole glutamic acid, about 12.9 mole % proline, about 8.9 mole % glycine, about 5.6 mole % alanine, about 5.4 mole % valine, about 1.2 mole % methionine, about 6.4 mole % isoleucine, about 9.2 mole % leucine, about 0.9 mole % tyrosine, about 2.8 mole % phenylalanine about 1.3 mole % histidine, about 1.8 mole % lysine and about 4.8 mole % arginine.
Claim 3
Dependent Claim
62 words
A bovine glycoprotein according to claim 1 which contains in the order of about 10% by weight of a complex glycolipid and which also contains hexose, sialic acid, N-acetylgalactosamine and N-acetylglucosamine in the approximate molar ratio 1.4:1:0.4:0.5, further characterized by its ability to give a single band upon polyacrylamide gel electrophoresis when stained with Coomassie blue or periodic acid modified Schiff reagent.
Claim 4
Dependent Claim
11 words
A bovine glycoprotein according to claim 1 which is essentially homogeneous.
Claim 5
Dependent Claim
203 words
A process for preparing the bovine glycoprotein of claim 2 which comprises the steps of: (a) uniformly suspending dried, ground, hemoglobin-free stroma from bovine erythrocytes in anhydrous acetone; (b) refluxing for from about 1 to about 6 hours, filtering and drying the residue; (c) suspending said dried residue in 100% anhydrous ethanol; (d) refluxing for from 1 to about 6 hours, filtering and drying the residue; (e) suspending the dried residue from step (d) in aqueous ethanol of from about 50% to about 80% strength and repeating step (b); (f) dissolving the residue from step (e) in water and adding 90% aqueous ethanol, followed by incubating on ice, until crystallization occurs, centrifuging and dialyzing the solid layer against a low pH, low ionic strength buffer; (g) passing the solid from step (f) through a cation exchange resin on a chromatographic column; (h) collecting the sialic acid containing fractions from the column and drying them; (i) treating the collected fractions from step (h) by extraction with a known lipid solvent, centrifuging, collecting the aqueous layer and drying it; (j) repeating step (i) on the product of that step, using a different lipid solvent, and (k) recovering the product of claim 2 in lyophilized form.
Claim 6
Dependent Claim
13 words
A process according to claim 4 wherein the cation exchange resin is phosphocellulose.
Claim 7
Dependent Claim
29 words
A process according to claim 4 wherein the lipid solvent of step (i) is diethyl ether and ethanol in a ratio by volume between about 4:1 and about 1:1.
Claim 8
Dependent Claim
25 words
A process according to claim 4 in which the lipid solvent of step (j) is chloroform and methanol in a volume ratio of about 2:1.
Claim 9
Dependent Claim
16 words
A process according to claim 4 wherein the solvent in step (e) is 75% aqueous ethanol.
Claim 10
Dependent Claim
84 words
A process for preparing the bovine glycoprotein of claim 3 which comprises the steps of, (a) dissolving the bovine glycoprotein from claim 2 in a low ionic strength buffer containing about 1% neutral detergent; (b) loading the solution of an anion exchange chromatographic column; (c) washing thoroughly with low ionic strength buffer; (d) eluting the column with aqueous buffer to high salt concentration, and (e) dialyzing the product of step (d) against water and recovering the product of claim 3 in freeze dried form.
Claim 11
Dependent Claim
114 words
A process for diagnosing infectious mononucleosis which comprises the steps of, (a) appending to minute particles of latex or synthetic resin the bovine glycoprotein of claim 2 or claim 3; (b) coating a flat surface with particles from step (a) hereof; (c) adding a diluted sample of biological test fluid from a patient suspected of harboring infectious mononucleosis, rotating the flat surface; (d) observing the degree of agglutination of the sample and, (e) comparing the result of step (d) with the degree of agglutination observed when a standard containing a known amount of infectious mononucleosis heterophile antibody is substituted as the sample in step (c) of the procedure recited in steps (a) through (d).
Claim 12
Dependent Claim
30 words
A bovine glycoprotein according to claim 1, containing a label selected from the group consisting of radioisotopes, fluorogens, chromophores, enzymes, luminescent substances and other known labels used in immunoassay procedures.
Claim 13
Dependent Claim
14 words
The labelled bovine glycoprotein of claim 11 in which the label is 125 I.
Claim 14
Dependent Claim
35 words
A radioimmunoassay procedure for determining the quantity of heterophile antibody of human infectious mononucleosis that is present in a test fluid sample wherein the antigen for said antibody comprises labelled bovine glycoprotein of claim 12.
Claim 15
Dependent Claim
15 words
A procedure according to claim 13 in which the radioimmunoassay is of the sandwich type.
Claim 16
Dependent Claim
14 words
A procedure according to claim 13 in which the radioimmunoassay is a competition assay.
Claim 17
Dependent Claim
20 words
A radioimmunoassay procedure according to claim 15 in which bovine glycoprotein of claim 3 is bound to a solid surface.
Claim 18
Dependent Claim
72 words
A bovine glycoprotein according to claim 1 containing essentially no glycolipid and having a carbohydrate content of approximately 25 weight percent, comprising hexose, sialic acid, N-acetylgalactosamine and N-acetylglucosamine in the approximate molar ratio of 1.6:1.0:0.5:1.1, further characterized by a protein content of approximately 75 weight percent and by its ability to give essentially a single band upon polyacrylamide gel electrophoresis when stained with Coomassie blue or with periodic acid modified Schiff reagent.
Claim 19
Dependent Claim
84 words
A process for preparing the bovine glycoprotein of claim 17 which comprises the steps of, (a) dissolving the bovine glycoprotein from claim 2 in a low ionic strength buffer containing about 1% neutral detergent; (b) loading the solution on an anion exchange chromatographic column; (c) washing thoroughly with low ionic strength buffer; (d) eluting the column with aqueous buffer to high salt concentration, and (e) dialyzing the product of step (d) against water and recovering the product of claim 17 in freeze dried form.
Claim 20
Dependent Claim
111 words
A process for diagnosing infectious mononucleosis which comprises the steps of, (a) appending to minute particles of latex or synthetic resin the bovine glycoprotein of claim 17; (b) coating a flat surface with particles from step (a) hereof; (c) adding a diluted sample of biological test fluid from a patient suspected of harboring infectious mononucleosis, rotating the flat surface; (d) observing the degree of agglutination of the sample and, (e) comparing the result of step (d) with the degree of agglutination observed when a standard containing a known amount of infectious mononucleosis heterophile antibody is substituted as the sample in step (c) of the procedure recited in steps (a) through (d).
Claim 21
Dependent Claim
30 words
A bovine glycoprotein according to claim 17, containing a label selected from the group consisting of radioisotopes, fluorogens, chromophores, enzymes, luminescent substances and other known labels used in immunoassay procedures.
Claim 22
Dependent Claim
14 words
The labelled bovine glycoprotein of claim 20 in which the label is 125 I.
Claim 23
Dependent Claim
34 words
A radioimmunoassay procedure for determining the quantity of heterophile antibody of human infectious mononucleosis that is present in a test sanple wherein the antigen for said antibody comprises labelled bovine glycoprotein of claim 21.
Claim 24
Dependent Claim
15 words
A procedure according to claim 22 in which the radioimmunoassay is of the sandwich type.
Claim 25
Dependent Claim
14 words
A procedure according to claim 23 in which the radioimmunoassay is a competition assay.
Claim 26
Dependent Claim
25 words
A radioimmunoassay procedure according to claim 24 in which is unlabeled bovine glycoprotein corresponding to the labelled bovine glycoprotein is bound to a solid surface.
References Cited (Backward Citations)
US3426123A
Cited
US3826821A
Cited
US3639558A
Cited
US3840655A
Cited
US3882225A
Cited
US3708572A
Cited
US3857931A
Cited
US3959456A
Cited
US3864467A
Cited
US4046723A
Cited
US4228148A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-07-17 | 1988-01-16 | 1988-07-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-07-17 | 1992-01-16 | 1992-07-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-07-17 | 1996-01-16 | 1996-07-17 | $7700.00 | Window Closed / Lapsed |